[
    [
        {
            "time": "",
            "original_text": "胰岛素集采或即将启动；扬子江宣布接班人；百济神州赴科创板上市；绿叶制药博优诺获批新适应证",
            "features": {
                "keywords": [
                    "胰岛素集采",
                    "扬子江",
                    "接班人",
                    "百济神州",
                    "科创板上市",
                    "绿叶制药",
                    "博优诺",
                    "新适应证"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "胰岛素集采或即将启动",
                "Correlation": 8,
                "Sentiment": 4,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]